PBI7 Cost-Effectiveness Analysis of Adalimumab Biosimilar Compared to Delayed Biologic Treatment Initiation in Patients with Rheumatoid Arthritis in Germany

Value in Health ◽

10.1016/j.jval.2021.04.078 ◽

2021 ◽

Vol 24 ◽

pp. S15

Author(s):

J. Porter ◽

P. Stuart ◽

R. Bartsch ◽

A. Lebioda

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Treatment Initiation ◽

Cost Effectiveness Analysis ◽

Biologic Treatment ◽

Effectiveness Analysis

Download Full-text

PBI19 Cost-Effectiveness Analysis of Adalimumab Biosimilar for Rheumatoid Arthritis in Brazil Compared to Delayed Biologic Treatment Initiation

Value in Health ◽

10.1016/j.jval.2020.08.097 ◽

2020 ◽

Vol 23 ◽

pp. S413-S414

Author(s):

S. Tanaka ◽

J.K. Porter ◽

F. Santos ◽

G. Aratangy

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Treatment Initiation ◽

Cost Effectiveness Analysis ◽

Biologic Treatment ◽

Effectiveness Analysis

Download Full-text

PMS44 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT

Value in Health ◽

10.1016/j.jval.2018.09.1758 ◽

2018 ◽

Vol 21 ◽

pp. S295

Author(s):

E. Öksüz ◽

S. Malhan ◽

L. Yanik ◽

E. Koc ◽

E. Erdogan-Ciftci ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Rheumatoid Arthritis Treatment ◽

Effectiveness Analysis

Download Full-text

PMS17 COST EFFECTIVENESS ANALYSIS OF UPADACITINIB AND METHOTREXATE FOR PATIENTS WITH METHOTREXATE-RESISTANT RHEUMATOID ARTHRITIS

Value in Health ◽

10.1016/j.jval.2020.04.704 ◽

2020 ◽

Vol 23 ◽

pp. S217

Author(s):

S. Jadhav ◽

Y. Yang

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2021.1834384 ◽

2020 ◽

pp. 1-10

Author(s):

Behzad Fatemi ◽

Soheila Rezaei ◽

Saeed Taheri ◽

Farzad Peiravian

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Active Rheumatoid Arthritis ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis Of Etanercept Versus Available Anti-Tnf And Il-6 Blockers For Treating Rheumatoid Arthritis In El Salvador

Value in Health ◽

10.1016/j.jval.2013.03.1138 ◽

2013 ◽

Vol 16 (3) ◽

pp. A224

Author(s):

M.A. Lutz ◽

R. Zelaya ◽

J.P. Bogantes ◽

G. Cuesta

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

El Salvador ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

PMS22 COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO

Value in Health ◽

10.1016/j.jval.2011.02.707 ◽

2011 ◽

Vol 14 (3) ◽

pp. A127

Author(s):

J. Vargas-Valencia ◽

M. Sotelo-Guzmán ◽

J.F. Mould-Quevedo ◽

E. Muciño-Ortega ◽

R.M. Galindo-Suarez

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

809 IMMEDIATE OR DELAYED TREATMENT INITIATION WITH “PREVIR” CONTAINING REGIMENS IN HCV-INFECTED NAIVE GENOTYPE 1 (G1) PATIENTS WITHOUT SEVERE FIBROSIS? A COST-EFFECTIVENESS ANALYSIS (ANRS N°12188)

Journal of Hepatology ◽

10.1016/s0168-8278(13)60811-9 ◽

2013 ◽

Vol 58 ◽

pp. S331 ◽

Author(s):

S. Deuffic-Burban ◽

M. Schwarzinger ◽

V. Mallet ◽

S. Pol ◽

G.-P. Pageaux ◽

...

Keyword(s):

Cost Effectiveness ◽

Treatment Initiation ◽

Cost Effectiveness Analysis ◽

Delayed Treatment ◽

Effectiveness Analysis ◽

Severe Fibrosis

Download Full-text

Cost-Effectiveness Analysis Of Etanercept Versus Available Anti-Tnf And Il-6 Blockers For Treating Rheumatoid Arthritis In Costa Rica

Value in Health ◽

10.1016/j.jval.2013.03.1137 ◽

2013 ◽

Vol 16 (3) ◽

pp. A224

Author(s):

M.A. Lutz ◽

J.P. Bogantes ◽

G. Cuesta ◽

R. Saenz

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis

Clinical Rheumatology ◽

10.1007/s10067-021-05876-4 ◽

2021 ◽

Author(s):

Chongqing Tan ◽

Xia Luo ◽

Sini Li ◽

Lidan Yi ◽

Xiaohui Zeng ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Treat To Target ◽

Severe Rheumatoid Arthritis ◽

Effectiveness Analysis ◽

Biological Treatments

Download Full-text

Cost-Effectiveness Analysis of Tocilizumab in Rheumatoid Arthritis, in Colombia

Value in Health ◽

10.1016/j.jval.2013.08.1490 ◽

2013 ◽

Vol 16 (7) ◽

pp. A563

Author(s):

O. Gamboa ◽

D. Bárbosa ◽

L. Parada ◽

M. Latorre

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text